Literature DB >> 10217332

Dihydropyrimidine dehydrogenase activity in a Korean population.

D R Sohn1, M S Cho, P J Chung.   

Abstract

Dihydropyrimidine dehydrogenase (DPD) is the major metabolic enzyme in the catabolism of 5-fluorouracil, and the activity in normal tissues shows a wide variation among individuals. Recent studies demonstrate the relevance of DPD in the pharmacokinetics, toxicity, and antitumor efficacy of 5-fluorouracil. We investigated the DPD activity in peripheral blood mononuclear cell form 114 healthy subjects in Korea. The DPD activities in healthy volunteers were shown to follow a unimodal distribution. The mean of the activity was 0.28 +/- 0.16 nmol/min/mg protein. A wide (13-fold) intersubject variability was observed (range, 0.06-0.80 nmol/min/mg protein), and, on average, DPD activity in women (0.26 +/- 0.14) was 13% lower than in men (0.30 +/- 0.16). These findings indicate that the activity of DPD in this study was higher than in reports of research with French and white American populations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217332     DOI: 10.1097/00007691-199904000-00002

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  6 in total

1.  Evaluation of dihydropyrimidine dehydrogenase activity in South-west Asian, Kenyan and Ghanaian populations.

Authors:  J M Morsman; J Sludden; M M Ameyaw; J Githang'A; A Indalo; D Ofori-Adjei; H L McLeod
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

Review 2.  Colorectal cancer in Chinese patients: current and emerging treatment options.

Authors:  Leung Li; Brigette By Ma
Journal:  Onco Targets Ther       Date:  2014-10-04       Impact factor: 4.147

3.  Evolution of Dihydropyrimidine Dehydrogenase Diagnostic Testing in a Single Center during an 8-Year Period of Time.

Authors:  Marieke J H Coenen; Aimée D C Paulussen; Marc Breuer; Martijn Lindhout; Demis C J Tserpelis; Anja Steyls; Jörgen Bierau; Bianca J C van den Bosch
Journal:  Curr Ther Res Clin Exp       Date:  2018-10-31

4.  Racial and ethnic differences in capecitabine toxicity in patients with gastrointestinal tract cancers.

Authors:  Alicia Brazelton; Soham Yande; Rita Pope; Michael L Johnson; Benjamin Musher; Meghana V Trivedi
Journal:  Ann Gastroenterol       Date:  2022-02-15

Review 5.  Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature.

Authors:  Cassandra White; Rodney J Scott; Christine Paul; Andrew Ziolkowski; David Mossman; Stephen Ackland
Journal:  Pharmgenomics Pers Med       Date:  2021-12-09

6.  Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine?

Authors:  Marzia Del Re; Antonello Di Paolo; Ron H van Schaik; Guido Bocci; Paolo Simi; Alfredo Falcone; Romano Danesi
Journal:  EPMA J       Date:  2010-07-25       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.